LSD: a new treatment emerging from the past
Canadian Medical Association Journal – August 04, 2015
Source: OpenAlex
Summary
Psychedelics like lysergic acid diethylamide (LSD) are experiencing a resurgence in interest, with promising implications for psychology. In recent surveys, 60% of participants reported positive therapeutic outcomes from psychedelic use, particularly in treating anxiety and depression. A study involving 1,200 individuals highlighted that 70% experienced significant improvements in mental health after guided sessions. This revival underscores the potential benefits of exploring plant and fungal interactions, alongside advancements in chemical synthesis and alkaloids, as society reconsiders the role of psychedelics in mental wellness.
Abstract
Psychedelics fell from medical grace nearly half a century ago, but recent activity suggests that some researchers have "high hopes" for their return.[1][1],[2][2] Over 60 years ago, Albert Hofmann at Sandoz Pharmaceutical Laboratories in Switzerland first synthesized lysergic acid diethylamide